Testing An Investigational Drug With Standard Treatment Before Surgery For Rectal Cancer
Posted Date: May 15, 2019
- Investigator: Jordan Kharofa
- Type of Study: Drug
NRG-GI002
Criteria:
To Be Eligible To Participate In This Study, Patients Must Have Rectal Cancer That Is Considered Loc
Keywords:
Cancer, Gi, Nrg-Gi002, Phase Ii, Rectal Cancer
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com